Stay updated on CMP-001 with Pembrolizumab: Clinical Trial
Sign up to get notified when there's something new on the CMP-001 with Pembrolizumab: Clinical Trial page.

Latest updates to the CMP-001 with Pembrolizumab: Clinical Trial page
- Check2 days agoChange DetectedThe page history now shows a new site revision: Revision: v3.3.3, and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2. These are site-wide updates rather than changes to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedOnly the revision label was updated from v3.3.1 to v3.3.2; no other content appears changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 in the Record History, indicating a metadata update to the page version. No trial data, eligibility criteria, or study details were modified.SummaryDifference0.1%

- Check38 days agoChange DetectedThe site-wide notice about a lapse in government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check52 days agoChange DetectedThe screenshots show the same record history content with only minor visual/UI adjustments; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedOverall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.SummaryDifference10%

Stay in the know with updates to CMP-001 with Pembrolizumab: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 with Pembrolizumab: Clinical Trial page.